Predictors of survival among Japanese patients receiving first-line chemoimmunotherapy for advanced non-small cell lung cancer.

Yuri OguraNobutaka KataokaYusuke KunimatsuYusuke TachibanaTakumi SugimotoNozomi TaniIzumi SatoKazuki HiroseDaishiro KatoTakayuki Takeda

Published in: Thoracic cancer (2020)

Repetitive evaluation of immunological and nutritional markers may be useful for guiding prognostication and treatment selection for Japanese patients with advanced lung cancer.

Keyphrases

advanced non small cell lung cancer
epidermal growth factor receptor
high frequency
combination therapy
tyrosine kinase